Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.

about

Serum relaxin-3 hormone relationship to male delayed puberty.Using a spontaneous profile rather than stimulation test makes the KIGS idiopathic growth hormone deficiency model more accessible for clinicians.

P2860

Q48275831-0B51E9BE-A62E-475E-A2B3-60A5D0BC224E Q48644407-4E7E78D2-D387-4CF9-BA15-BEC840A0A1ED

P2860

Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.

Item

http://www.wikidata.org/entity/Q35872930

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.

@ast

Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.

@en

type

Item

label

Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.

@ast

Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.

@en

prefLabel

Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.

@ast

Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.

@en

P1476

Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.

@en

P2093

Berit Kriström

http://www.w3.org/2001/XMLSchema#string

Bjorn Jonsson

http://www.w3.org/2001/XMLSchema#string

Elena Lundberg

http://www.w3.org/2001/XMLSchema#string

study group

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

The first-year growth response to growth hormone treatment predicts the long-term prepubertal growth response in children

Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).

Non-compliance with growth hormone treatment in children is common and impairs linear growth.

Different thresholds of tissue-specific dose-responses to growth hormone in short prepubertal children

Observations of nonadherence to recombinant human growth hormone therapy in clinical practice.

Evo-devo of infantile and childhood growth.

Predicting growth in response to growth hormone treatment.

Noncompliance in adolescents: a review.

I. physical growth from birth to 16 years and longitudinal outcome of the study during the same age period.

P2888

s12902-015-0080-8

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12902-015-0080-8

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kerstin Albertsson Wikland

P577

2015-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

287483553

http://www.w3.org/2001/XMLSchema#string

P6179

1040319709

http://www.w3.org/2001/XMLSchema#string

P698

26682747

http://www.w3.org/2001/XMLSchema#string

P932

4683753

http://www.w3.org/2001/XMLSchema#string

Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.

about

P2860

P2860

Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932